Related Experiment Video
Updated: Aug 7, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Takayasu's arteritis: An update on physiopathology
Laurent Arnaud1, Jean-Emmanuel Kahn, Nicolas Girszyn
1Department of Internal Medicine, Foch Hospital, 40 rue Worth, F-92150 Suresnes, France.
European Journal of Internal Medicine
|June 10, 2006
Summary
Takayasu's arteritis involves complex immune responses, including cellular and humoral immunity, leading to vascular inflammation. Understanding these mechanisms may reveal new therapeutic targets for this large vessel vasculitis.
Area of Science:
- Immunology
- Rheumatology
- Vascular Biology
Background:
- Takayasu's arteritis (TA) is a chronic large vessel vasculitis with incompletely understood pathophysiology.
- Immune system dysregulation, particularly cellular immunity, is implicated in TA development.
Purpose of the Study:
- To elucidate the immunological mechanisms underlying vascular injury in Takayasu's arteritis.
- To identify potential therapeutic targets based on the disease's immunopathology.
Main Methods:
- Review of the proposed pathological sequence in TA.
- Analysis of immune cell involvement, including T-cells, NK cells, and dendritic cells.
- Examination of molecular pathways such as HSP-65, MICA, and cytokine signaling.
Main Results:
- TA pathogenesis involves antigen stimulation, heat shock protein (HSP)-65 expression, and MICA induction.
- Immune cells like T-cells and NK cells recognize MICA, triggering inflammation via pro-inflammatory cytokines.
- Humoral immunity develops, with anti-endothelial cell autoantibodies contributing to vascular damage.
Conclusions:
- TA involves a complex interplay of cellular and humoral immune responses targeting vascular tissue.
- Current treatments include corticosteroids and immunosuppressants, with emerging therapies targeting TNF-alpha.
- Further understanding of TA immunopathology may lead to novel, targeted treatments.
Related Concept Videos
01:22Pericarditis I: Introduction
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...